Search

The electropolishing behavior of pure magnesium and its alloys in ethylene glycol (EG), diethylene glycol (DEG), triethylene glycol (TrEG), and tetraethylene glycol (TeEG) solutions containing sodium chloride was investigated using electrochemical measurements, microscopic observations, and reflectance measurements. Large light-grayish cloudy areas with micrometer-scale linear irregularities were formed on the magnesium surface via constant-voltage electrolysis in the EG solution, whereas mirror-finished magnesium surfaces were successfully obtained in the DEG and TeEG solutions. Among these, the DEG solution is considered appropriate for electropolishing because of its lower viscosity and market price. The reflectance of the entire visible wavelength region gradually increased with time during electrolysis in the DEG solution at 308 K. We found that short-term electrolysis for 3 min at the higher voltage of 75 V should be selected if a moderately polished surface is to be rapidly obtained, whereas long-term electrolysis for 60–300 min at 50 V should be performed if a highly polished surface with an extremely high reflectivity measuring more than 80% can be obtained. Three-dimensional magnesium specimens with curved and spiral shapes and an LZ91 magnesium alloy consisting of a simple solid-solution matrix can also be electropolished via electrolysis in a DEG solution. [ABSTRACT FROM AUTHOR]

Reductive N‐11C‐methylation using [11C]formaldehyde and amines has been used to prepare N‐11C‐methylated compounds. However, the yields of the N‐11C‐methylated compounds are often insufficient. In this study, we developed an efficient method for base‐free reductive N‐11C‐methylation that is applicable to a wide variety of substrates, including arylamines bearing electron‐withdrawing and electron‐donating substituents. A 2‐picoline borane complex, which is a stable and mild reductant, was used. Dimethyl sulfoxide was used as the primary reaction solvent, and glacial acetic acid or aqueous acetic acid was used as a cosolvent. While reductive N‐11C‐methylation efficiently proceeded under anhydrous conditions in most cases, the addition of water to the reductive N‐11C‐methylation generally increased the yield of the N‐11C‐methylated compounds. Substrates with hydroxy, carboxyl, nitrile, nitro, ester, amide, and phenone moieties and amine salts were applicable to the reaction. This proposed method for reductive N‐11C‐methylation should be applicable to a wide variety of substrates, including thermo‐labile and base‐sensitive compounds because the reaction was performed under relatively mild conditions (70°C) without the need for a base. [ABSTRACT FROM AUTHOR]

Background: To identify predictive factors associated with successful transition to conversion therapy following combination therapy with atezolizumab and bevacizumab in the treatment of unresectable hepatocellular carcinoma (HCC). Methods: In total, 188 patients with HCC, who received atezolizumab plus bevacizumab combination therapy as the first‐line chemotherapy, were studied. Patients who achieved complete response (CR) with systemic chemotherapy alone were excluded. Clinical factors possibly linked to successful transition to conversion therapy and the achievement of cancer‐free status were identified. Results: Fifteen (8.0%) patients underwent conversion therapy. In the conversion group, there was a significantly higher proportion of patients with Barcelona Clinic Liver Cancer (BCLC) stage A or B (73.3% versus [vs.] 45.1%; p =.03) and tended to have lower Child‐Pugh scores and alpha‐fetoprotein levels. Multivariate analysis revealed that BCLC stage was a predictive factor for the implementation of conversion therapy (A or B; odds ratio 3.7 [95% CI: 1.1–13]; p =.04). Furthermore, 10 (66.7%) patients achieved cancer‐free status and exhibited a smaller number of intrahepatic lesions at the start of treatment (3.5 vs. 7; p <.01), and a shorter interval between systemic chemotherapy induction and conversion therapy (131 vs. 404 days; p <.01). In addition, the rate of achieving cancer‐free status by undergoing surgical resection or ablation therapy was significantly higher (p =.03). Conclusion: BCLC stage was the sole predictive factor for successful transition to conversion therapy when using combination therapy with atezolizumab and bevacizumab to treat HCC. Furthermore, a small number of intrahepatic lesions and early transition to conversion therapy were associated with the achievement of cancer‐free status. [ABSTRACT FROM AUTHOR]

Background: Multidrug resistance-associated protein 1 (MRP1), an energy-dependent efflux pump, is expressed widely in various tissues and contributes to many physiological and pathophysiological processes. 6-Bromo-7-[11C]methylpurine ([11C]7m6BP) is expected to be useful for the assessment of MRP1 activity in the human brain and lungs. However, the radiochemical yield (RCY) in the synthesis of [11C]7m6BP was low, limiting its clinical application, because the methylation of the precursor with [11C]CH3I provided primarily the undesired isomer, 6-bromo-9-[11C]methylpurine ([11C]9m6BP). To increase the RCY of [11C]7m6BP, we investigated conditions for improving the [11C]7m6BP/[11C]9m6BP selectivity of the methylation reaction. Results: [11C]7m6BP was manually synthesized via the methylation of 6-bromopurine with [11C]CH3I in various solvents and at different temperatures in the presence of potassium carbonate for 5 min. Several less polar solvents, including tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), and ethyl acetate (AcOEt) improved the [11C]7m6BP/[11C]9m6BP selectivity from 1:1 to 2:1, compared with the conventionally used solvents for the alkylation of 6-halopurines, acetone, acetonitrile, and N,N-dimethylformamide. However, a higher temperature (140 °C or 180 °C) was needed to progress the 11C-methylation in the less polar solvents, and the manual conditions could not be directly translated to an automated synthesis. [11C]Methyl triflate ([11C]CH3OTf) was thus used as a methylating agent to increase the conversion at a lower temperature. The 11C-methylation using [11C]CH3OTf at 100 °C proceeded efficiently in THF, 2-MeTHF, and AcOEt with maintenance of the improved selectivity. Starting from 28 to 34 GBq [11C]CO2, [11C]7m6BP was produced with 2.3–2.6 GBq for THF, 2.7–3.3 GBq for AcOEt, and 2.8–3.9 GBq for 2-MeTHF at approximately 30 min after the end of bombardment (n = 3 per solvent). The isolated RCYs (decay corrected) for THF, 2-MeTHF, and AcOEt were 24–28%, 29–35%, and 22–31% (n = 3), respectively. Conclusions: The use of THF, 2-MeTHF, and AcOEt improved the [11C]7m6BP/[11C]9m6BP selectivity in the methylation reaction, and the improved method provided [11C]7m6BP with sufficient radioactivity for clinical use. [ABSTRACT FROM AUTHOR]

Background and Aim: Anticoagulant users with nonvalvular atrial fibrillation (NVAF) sometimes suffer from gastrointestinal bleeding (GIB) and have difficulty continuing the medication. Left atrial appendage closure (LAAC) has been developed for such situations. We aimed to clarify the clinical significance of a history of GIB in comparison to other factors in patients who had undergone LAAC. Methods: From October 2019 to September 2023, patients with NVAF who underwent LAAC at our hospital were enrolled. We investigated the percentage of patients with a history of GIB who underwent LAAC and compared the incidence of post‐LAAC bleeding in these patients compared to those with other factors. Results: A total of 45 patients were included. There were 19 patients (42%) with a history of GIB who underwent LAAC. In a Kaplan–Meier analysis, the cumulative incidence of bleeding complications after LAAC was significantly higher in patients with a history of GIB in comparison to patients with other factors. There were eight cases of post‐LAAC bleeding in total, and seven cases had GIB. Conclusions: We need to recognize that GIB is a significant complication in patients who undergo LAAC. The management of GIB by gastroenterologists is essential to the success of LAAC. [ABSTRACT FROM AUTHOR]

The polychromatic incident energy measurements using chopper spectrometers at pulsed sources enables us to measure dynamics with different energy resolutions, i.e., different time-windows with a single-measurement. By increasing the possible time-window for a single-measurement, the efficiency and usefulness of such measurements is enhanced. This is achieved by allowing the crossing of trajectories of different Eis from different source pulses on the time-of-flight diagram (the interveined trajectory). We will present an actual case of the interveined trajectory on AMATERAS, a cold-neutron chopper spectrometer installed at J-PARC, together with our experience. Some of our attempts to formulate the conditions for performing polychromatic Ei measurements employing interveined trajectories are discussed. These which can be applied to existing spectrometers, and considered as design criteria for future chopper spectrometers. Further related plan of AMATERAS to improve measuring efficiency is also mentioned.